Sign in

CIK 0001728117

  • Non-accelerated filer
  • Smaller reporting company

Gossamer Bio, Inc.

Sign in to watch
Ticker
GOSS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
475461709
Phone
+1 858-684-1300
Business address
3115 MERRYFIELD ROW, SUITE 120, SAN DIEGO, CA, 92121
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 6 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-09-23 Milligan Sandra Director Grant or award · Stock Option (Right to Buy) +10,000 10,000
2026-06-04 Milligan Sandra Director Grant or award · Stock Option (Right to Buy) +115,000 115,000
2025-08-19 Milligan Sandra Director Purchase +26,050 $1.92 $50K 58,050
2025-06-25 Milligan Sandra Director Grant or award · Stock Option (Right to Buy) +115,000 115,000
2024-06-06 Milligan Sandra Director Grant or award · Non-qualified stock option (Right to Buy) +115,000 115,000
2023-11-15 Milligan Sandra Director Purchase +32,000 $0.79 $25K 32,000
2023-06-08 Milligan Sandra Director Grant or award · Stock Option (Right to Buy) +35,000 35,000
2022-06-09 Milligan Sandra Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2021-06-10 Milligan Sandra Director Grant or award · Stock Option (Right to Buy) +47,000 47,000

Page 1 of 1 · 9 trades